Cardiology Review: Murmurs, Exams, Pericarditis to Atrial Fibrillation
Cardiac Exam: Murmurs, Sounds, and Basic Cardiac Anatomy
Palpation findings you should recall during a cardiac exam:
Thrill: a palpable vibration felt over the chest, like a motor purring; often graded on a 0–6 scale, with a 4/6 being described here as a loud thrill. May be present with shunts like a ventricular septal defect (VSD).
Lift or heave: a sustained impulse felt or seen on inspection, suggesting ventricular hypertrophy or dilated cardiomyopathy (enlarged heart chambers).
Murmur grading realism: in early PA practice, many appear normal; over time, you learn to distinguish louder vs softer murmurs and when a thrill is present.
Palpation and auscultation locations for murmurs:
Aortic area: 2nd right intercostal space (ICS)
Pulmonic area: 2nd left ICS
Tricuspid area: 4th left ICS
Mitral area: 5th left ICS at the midclavicular line
Murmurs radiate to other areas depending on the valve involved; the sound radiates rather than being exactly over the valve.
A helpful reminder: murmurs are often best heard in the area where the sound radiates, not necessarily at the valve’s exact location.
Clinicians: when a question says, for example, a systolic murmur at the second intercostal space on the right, think aortic valve involvement; questions are often worded to help you narrow the valve.
Basic flow of blood through the heart (overview for orientation):
Systemic venous return via the superior and inferior vena cavae drains into the right atrium (RA).
RA → tricuspid valve → right ventricle (RV) during diastole.
RV → pulmonic valve → pulmonary arteries → lungs for oxygenation.
Oxygenated blood returns via the pulmonary veins → left atrium (LA).
LA → mitral valve → left ventricle (LV) during diastole.
LV → aortic valve → aorta → systemic circulation.
A note on pulmonary embolism (PE) anatomy:
Saddle PE occurs at the bifurcation of the pulmonary arteries and can cause obstructive shock.
Core heart sounds and their timing:
S1: occurs when the mitral and tricuspid valves close; marks the beginning of systole (ventricular contraction and ejection).
S2: occurs when the aortic and pulmonic valves close; marks the beginning of diastole (ventricular filling).
LV/RV valves (aortic and pulmonic) close at about the same time; AV valves (mitral and tricuspid) close almost simultaneously.
S2 is loudest at the base of the heart; S1 at the apex.
Normal vs abnormal S2 splitting:
Normal physiological S2 split: during inspiration, the pulmonic valve closes slightly later than the aortic valve, widening the split. This is normal and should be heard with deep inspiration.
Fixed split S2: does not vary with respiration and is associated with an atrial septal defect (ASD); the split persists on inspiration and expiration.
S3 and S4 gallops (timing and clinical significance):
S3 gallop: early diastole, after S2; associated with volume overload and congestive heart failure (CHF) in adults; can be normal in young athletes (athletic heart). Remember the phrase: "sloshing in" (S1, S2, S3 – diastolic filling time).
S4 gallop: late diastole, just before S1; indicates a stiff ventricle (e.g., longstanding hypertension with LV hypertrophy or post-MI scar); never normal.
Mnemonic memory aids: S3 associated with CHF or athletic heart; S4 with stiff ventricle (stiff wall).
Functional (physiologic) murmurs:
Occur in states of high cardiac output with no primary valve pathology.
Typical scenarios: pregnancy, anemia, young athletes with increased flow.
These murmurs are not due to structural valve disease; they arise from increased flow across a normal valve.
Murmur timing reminder:
Systolic murmurs occur between S1 and S2.
Diastolic murmurs occur between S2 and S1.
If unsure of a murmur’s timing, palpate the carotid pulse or the point of maximal impulse (PMI) to correlate with murmur timing (if the murmur coincides with the pulse, it’s typically systolic).
Four systolic murmurs and two diastolic murmurs to know for boards (brief overview):
Systolic murmurs: Mitral regurgitation (MR), Aortic stenosis (AS), Tricuspid regurgitation (TR), Pulmonic stenosis (PS).
Diastolic murmurs: Aortic regurgitation (AR), Mitral stenosis (MS).
Mnemonic for diastolic murmurs: ARMS (Aortic regurgitation, Mitral stenosis).
Systolic murmur details and pathophysiology
Mitral regurgitation (MR):
Timing: holosystolic (throughout S1–S2).
Location/quality: apical, radiates to the axilla; blowing quality; best heard at the apex.
Etiology: mitral valve prolapse (MVP), LV dysfunction with dilation, ischemic heart disease, papillary muscle rupture (post-MI, acute MR).
Clinical notes: volume overload; S3 may be present; may lead to pulmonary edema.
Treatment: valve repair preferred if possible; if not, valve replacement.
Aortic stenosis (AS):
Timing: systolic murmur; harsh, crescendo-decrescendo pattern; best heard at the 2nd right ICS.
Radiation: to the carotids.
Etiology: congenital bicuspid aortic valve or calcific degeneration with age.
Symptoms/signs: syncope with exertion, angina, dyspnea on exertion; beware exercise stress testing if unaddressed AS.
Management: aortic valve replacement (AVR) or transcatheter aortic valve replacement (TAVR).
Tricuspid regurgitation (TR):
Timing: holosystolic/pansystolic murmur; best heard at left lower sternal border.
Radiation: may radiate to the right or lower sternum; louder with inspiration (Carvallo’s sign).
Etiology: pulmonary hypertension, rheumatic disease, IV drug use with endocarditis, Ebstein anomaly.
Clinical notes: signs of right-sided failure (JVD, edema, ascites).
Treatment: diuretics; valve repair or replacement if severe.
Pulmonic stenosis (PS):
Timing: systolic murmur; best heard at the 2nd left ICS.
Etiology: often congenital.
Diastolic murmurs details
Aortic regurgitation (AR):
Timing: blowing, decrescendo diastolic murmur; best heard at left sternal border (Erb’s point, 3rd ICS); may be accentuated when leaning forward and holding breath.
Etiology: hypertension with aortic root dilation, aortic dissection, Marfan syndrome.
Physical findings: wide pulse pressure (e.g., 150/40); Corrigan (water-hammer) pulse; Traube sign; pistol-shot femoral pulses (Traube sign).
Symptoms: angina, dyspnea due to volume overload.
Treatment: aortic valve replacement.
Mitral stenosis (MS):
Timing: diastolic rumble with an opening snap after S2 (hard to hear but classic when present).
Etiology: typically rheumatic heart disease following untreated group A streptococcal infection.
Clinical notes: risk of atrial fibrillation due to LA enlargement.
Treatment: valve replacement when indicated; manage AFI risk.
Valve repair versus replacement concepts
Valve repair: leaves existing leaflets intact; ring annuloplasty to tighten the valve and improve coaptation.
Valve replacement: replace with a tissue valve (bovine or porcine) or a mechanical valve.
Anticoagulation implications:
Tissue valves: typically anticoagulation for ~1–2 months post-operation; then may discontinue.
Mechanical valves: long-term anticoagulation required due to thrombosis risk.
Anticoagulation specifics:
Warfarin: vitamin K antagonist; INR target typically between 2.0\le INR\le 3.0.
Reversal: vitamin K; fresh frozen plasma (FFP) for urgent reversal in active bleeding; dietary considerations with leafy greens.
Drug interactions: grapefruit juice and alcohol can increase INR; various drugs can affect warfarin metabolism.
Hypertrophic obstructive cardiomyopathy (HOCM)
Pathophysiology: thickened interventricular septum causing dynamic LV outflow tract obstruction; linked to sudden cardiac death in athletes.
Physical exam concepts: murmur that worsens with decreased preload; dynamic obstruction.
Maneuvers that affect preload and murmur intensity:
Squatting increases preload; often reduces murmur intensity.
Standing and Valsalva reduce preload; murmur intensity increases.
Handgrip (not emphasized here) can also affect murmur depending on afterload.
Clinical approach: differentiate from AS; consider sports physicals for athletes; echocardiography for diagnosis.
Mitral valve prolapse (MVP)
Features: midsystolic click with or without late systolic murmur; palpitations and dysautonomia symptoms in some patients.
Valsalva/standing effects: murmur can be accentuated with standing or Valsalva due to decreased preload.
Management: beta-blockers for symptoms; echo to confirm; repair if severe regurgitation.
Inflammation and infection in the heart
Pericarditis (inflammation of the pericardium):
Causes: viral infections, TB, cancer, lupus, rheumatoid arthritis; drugs (minoxidil, penicillin, chemotherapy).
Dressler syndrome (post-MI or post-CABG pericarditis): common after MI or bypass surgery; fibrinous pericarditis.
Symptoms: sharp chest pain, worse with inspiration and lying flat; friction rub (sound like boot scraping in snow) is highly specific.
EKG findings: PR depression; diffuse concave upward ST elevations; J point notching occasionally.
Labs: ESR elevated; CRP elevated.
Treatment: NSAIDs (e.g., ibuprofen, indomethacin, naproxen) plus colchicine for ~3 months; avoid steroids due to recurrence risk.
Pericardial effusion and tamponade
Pathophysiology: buildup of fluid in the pericardial space compressing the heart and impairing diastolic filling.
Beck’s triad: hypotension, JVD, muffled heart tones.
Kussmaul sign: JVP increases on inspiration (noted in some cases).
Pulsus paradoxus: >10 mmHg drop in systolic BP with inspiration; observed as a sign of tamponade.
Electrical alternans on EKG: beat-to-beat QRS amplitude variation due to heart swinging in fluid.
Management: urgent pericardiocentesis with ultrasound guidance if unstable; pericardial window or drain if stable but large effusion; send fluid for pathology to assess malignancy or infection.
Myocarditis (inflammation of the heart muscle)
Etiology: usually viral; can be hypersensitivity or autoimmune; sometimes associated with vaccines.
Presentation: flu-like symptoms followed by dyspnea and possible heart failure signs; tachyarrhythmias.
Lab/EKG: elevated ESR/CRP; troponin elevated; ECG may show diffuse ST elevations similar to pericarditis but without STEMI features; heart blocks or ventricular arrhythmias possible.
Imaging/diagnosis: echocardiography to assess wall motion; cardiac MRI helpful; definitive etiology often from endomyocardial biopsy.
Treatment: heart failure management; avoid NSAIDs (can worsen heart failure); restrict activity for 3–6 months; monitor arrhythmias; treat underlying cause.
Infective endocarditis (IE)
Risk factors: prosthetic valves, IV drug use, pacemaker/ICD leads, prior valve disease, immunosuppression, dental or other procedures with potential bacteremia.
Presentation: fever, malaise; murmur; possible glomerulonephritis; vascular phenomena; rare findings such as splinter hemorrhages, Janeway lesions, Osler nodes, Roth spots.
Diagnosis: positive blood cultures; echocardiography (TEE is common for detection of vegetations).
Common pathogen: Staphylococcus aureus.
Treatment: antibiotics for roughly 2–6 weeks (often 4–6 weeks for native valves; longer for prosthetic valves).
Prophylaxis: antibiotic prophylaxis for dental work, certain GI/ GU procedures when bacteremia risk is high in patients with prosthetic valves or prior IE or certain high-risk conditions.
Rheumatic heart disease and related issues
Etiology: sequela of untreated group A streptococcal pharyngitis; rheumatic fever can affect joints and heart.
Cardiac impact: mitral valve most commonly affected in rheumatic disease; mitral stenosis is a classic worldwide complication.
Prevention and treatment: primary penicillin prophylaxis; valve surgery if severe.
Atrial fibrillation (A-fib) overview for exam prep
Pathophysiology: chaotic atrial activity with multiple foci leading to irregular, often rapid ventricular response; AV node reduces conduction to pacing rate.
Typical presentation: irregularly irregular rhythm; absence of discrete P waves; variable R-R intervals; tachycardia range often around 110–140 bpm in acute presentations.
Classifications: paroxysmal (terminates within 7 days), persistent (>7 days, may require cardioversion), permanent (accepted long-standing AF with no sinus rhythm).
Duration and thromboembolism risk: the 48-hour rule is a practical guide—AF lasting >48 hours increases risk of left atrial thrombus; risk stratification is essential for management decisions.
Initial evaluation and workup: history, ECG, baseline labs, echocardiography to assess atrial size and cardiomyopathy, assess for valvular disease; evaluate for precipitating factors (e.g., hyperthyroidism, sleep apnea, caffeine or energy drinks intake).
Rate control vs rhythm control:
Rate control options: beta blockers, calcium channel blockers, and digoxin.
Rhythm control options: antiarrhythmic drugs or electrical cardioversion; urgent if unstable.
Anticoagulation and stroke prevention:
CHADS-VASc score helps determine need for anticoagulation; general guidance from the lecture:
If CHADS-VASc = 0: no anticoagulation.
If CHADS-VASc = 1 (men) or 2 (women): consider none or anticoagulation; aspirin alone is not indicated for AF stroke prevention in this scenario.
If CHADS-VASc >= 2 (men) or >= 3 (women): anticoagulation indicated.
Anticoagulation options:
Warfarin (vitamin K antagonist): INR target ~2.0 ext{ to } 3.0; interactions with diet (vitamin K), drugs, and foods; reversal with vitamin K; FFP for urgent reversal in active bleeding; not recommended in pregnancy.
DOACs (direct oral anticoagulants): rivaroxaban, apixaban, edoxaban (Factor Xa inhibitors); preferred over warfarin in non-valvular AF without mitral stenosis; require dose adjustment for renal impairment; do not require routine INR monitoring; reversal agents exist but with varying accessibility.
Important caveat: DOACs are not used with significant mitral stenosis; warfarin remains preferred for AF with mitral stenosis.
Rhythm control strategies and procedures:
Direct current cardioversion (DCCV) when indicated; if AF duration >48 hours, anticoagulation for ~3 weeks before cardioversion or seek TEE-guided cardioversion to exclude LA thrombus; if unstable, cardioversion is urgent.
Pulmonary vein isolation (PVI) via catheter ablation as a curative approach for paroxysmal or some persistent AF.
Practical antiarrhythmics for AF (sample drugs):
Amiodarone (Class III): effective but notable toxicities (thyroid, liver, pulmonary toxicity); requires baseline and periodic monitoring; can prolong QT; pulmonary toxicity can be irreversible.
Sotalol (Class III with beta-blocker effect): QT prolongation risk; monitor QT.
Flecainide and Propafenone (Class Ic): require normal LV function and no significant CAD; use with caution in patients with structural heart disease.
Practical clinical question highlights (from the end of the lecture)
Pericarditis presentation with pleuritic chest pain and a friction rub; NSAIDs and colchicine are mainstays; avoid steroids due to recurrence risk; Dressler syndrome as a post-MI pericarditis variant.
Amiodarone pulmonary toxicity: consider in AF patients with pulmonary fibrosis on imaging or restrictive patterns on PFTs.
Tamponade signs: hypotension, JVD, muffled heart sounds; pulsus paradoxus; electrical alternans on EKG; management includes urgent pericardiocentesis if unstable, possibly pericardial window for ongoing effusion.
AF management in unstable patients: immediate synchronized cardioversion; if unstable, do not delay for anticoagulation.
Brief sample exam-style questions reviewed in class and their rationale (pericarditis treatment, amiodarone toxicity, tamponade, unstable AF management).
Key formulas, numbers, and clinical thresholds to memorize
Anticoagulation decision rule for AF (summary from CHADS-VASc):
If CHADS ext{-}VASc = 0: no anticoagulation.
If male with CHADS ext{-}VASc = 1 or female with CHADS ext{-}VASc = 2: consider no anticoagulation vs. anticoagulation; aspirin not routinely recommended for stroke prevention in AF.
If CHADS ext{-}VASc ext{ is }
promote 2 ext{ in men or }
promote 3 ext{ in women}: anticoagulation indicated.
Warfarin INR target: 2.0 \le INR \le 3.0.
Bypass/acute management notes:
If AF duration > 48 hours, anticoagulation for ~21 days (3 weeks) before cardioversion or perform TEE-guided cardioversion to exclude left atrial thrombus.
If AF duration < 48 hours and patient is unstable: proceed to synchronized cardioversion without waiting for anticoagulation.
Valve replacement choices and anticoagulation implications:
Tissue valve: typically short-term anticoagulation; often discontinue after 1–2 months.
Mechanical valve: long-term anticoagulation required (lifelong).
Classic murmurs location quick references (non-exhaustive):
Aortic stenosis: harsh systolic murmur at the 2nd right ICS radiating to the carotids.
Mitral regurgitation: holosystolic murmur at the apex radiating to the axilla.
Tricuspid regurgitation: pansystolic murmur best heard at the left lower sternal border; louder with inspiration.
Aortic regurgitation: diastolic blowing decrescendo murmur best heard at the left sternal border with patient in a leaning-forward position.
Be mindful of red flags in quarterback-style questions:
A-fib with murmur radiating to the neck suggests AS in the appropriate context.
Shortness of breath with prior MI and a new holosystolic murmur at the apex suggests MR due to LV dilation or papillary muscle dysfunction.
A mid-systolic click with a murmur that worsens with standing suggests MVP.
Connections to practice and real-world relevance
The timing and radiation of murmurs help distinguish valve pathologies in clinical exams and guide when to order further imaging (e.g., echocardiography) or consider surgical interventions.
Understanding preload effects on HOCM and MVP helps explain why certain physical maneuvers either worsen or improve the murmur, guiding recommendations for athletes and physical exams.
Recognizing pericarditis, pericardial effusion, and tamponade is crucial in acute care; prompt management can be life-saving, particularly in tamponade where hemodynamic collapse can occur rapidly.
AF management hinges on stroke risk (CHADS-VASc) and hemodynamic stability; choosing rate vs rhythm control and selecting anticoagulation strategy (warfarin vs DOACs) depends on valvular disease and patient-specific factors.
Infections (infective endocarditis) and rheumatic heart disease remain important globally; prophylaxis guidelines influence dental and invasive procedures for high-risk patients.
The evolving role of TAVR for aortic stenosis reflects less invasive options with favorable short-term outcomes and expanding indications.
The emphasis on not using NSAIDs in myocarditis and heart failure highlights nuanced aspects of pharmacotherapy in cardiology.
Recognizing the implications of rheumatic disease globally helps in understanding patient histories and anticipating valve involvement in younger patients.
If you want, I can convert these notes into a concise study sheet focused on specific exam-style questions or create a quick-reference card for how to approach auscultation and differentiating murmurs in a high-yield, exam-ready format.